(Reuters) -Swiss generic drug manufacturer Sandoz plans to introduce unbranded weight-loss drugs in Canada at up to a 70% discount compared to branded versions when patents begin expiring next year, CEO Richard Saynor told the Financial Times.
(Reporting by Bipasha Dey in Bengaluru; Editing by Nivedita Bhattacharjee)
Comments